Literature DB >> 16356121

Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death.

Renu A Kowluru1.   

Abstract

Oxidative stress is increased in the retina in diabetes; the levels of oxidatively modified DNA and nitrosylated proteins are elevated, and antioxidant defense enzymes are impaired. The levels of superoxides are elevated in the retina, and the mitochondria become dysfunctional with proapoptotic protein, Bax, translocating from the cytosol into the mitochondria, and cytochrome c leaking out from the mitochondria. This is accompanied by increased retinal capillary cell apoptosis, and the formation of acellular capillaries and pericyte ghosts, the early signs of retinopathy in animal models of diabetic retinopathy. Inhibition of superoxides inhibits glucose -induced mitochondrial dysfunction, activation of caspase-3, and cell death in retinal capillary cells. In animal models, long-term administration of lipoic acid or other antioxidants inhibits the development of diabetic retinopathy via inhibition of accumulation of oxidatively modified DNA and nitrotyrosine and capillary cell apoptosis in the retina. Understanding the role of mitochondria in the development of retinopathy in diabetes should help identify therapies that can neutralize superoxides and inhibit their dysfunction and, ultimately, the development of retinopathy. Antioxid. Redox Signal. 7, 1581-1587.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356121     DOI: 10.1089/ars.2005.7.1581

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  101 in total

1.  High glucose induces mitochondrial morphology and metabolic changes in retinal pericytes.

Authors:  Kyle Trudeau; Anthony J A Molina; Sayon Roy
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

2.  High glucose disrupts mitochondrial morphology in retinal endothelial cells: implications for diabetic retinopathy.

Authors:  Kyle Trudeau; Anthony J A Molina; Wen Guo; Sayon Roy
Journal:  Am J Pathol       Date:  2010-06-03       Impact factor: 4.307

Review 3.  From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.

Authors:  William A Banks
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

4.  Diabetic retinopathy and damage to mitochondrial structure and transport machinery.

Authors:  Qing Zhong; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

5.  Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?

Authors:  Renu A Kowluru; Qing Zhong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

6.  Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes.

Authors:  Moe H Aung; Han Na Park; Moon K Han; Tracy S Obertone; Jane Abey; Fazila Aseem; Peter M Thule; P Michael Iuvone; Machelle T Pardue
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

7.  TIAM1-RAC1 signalling axis-mediated activation of NADPH oxidase-2 initiates mitochondrial damage in the development of diabetic retinopathy.

Authors:  Renu A Kowluru; Anjaneyulu Kowluru; Rajakrishnan Veluthakal; Ghulam Mohammad; Ismail Syed; Julia M Santos; Manish Mishra
Journal:  Diabetologia       Date:  2014-02-20       Impact factor: 10.122

8.  Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase.

Authors:  Sally A Madsen-Bouterse; Qing Zhong; Ghulam Mohammad; Ye-Shih Ho; Renu A Kowluru
Journal:  Free Radic Res       Date:  2010-03

9.  Hyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models.

Authors:  Renu A Kowluru; Manish Mishra; Anjaneyulu Kowluru; Binit Kumar
Journal:  Metabolism       Date:  2016-07-30       Impact factor: 8.694

10.  Osmotic expression of aldose reductase in retinal pigment epithelial cells: involvement of NFAT5.

Authors:  Anica Winges; Tarcyane Barata Garcia; Philipp Prager; Peter Wiedemann; Leon Kohen; Andreas Bringmann; Margrit Hollborn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-09-14       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.